Cargando…

Striatal D(1) Dopamine Neuronal Population Dynamics in a Rat Model of Levodopa-Induced Dyskinesia

BACKGROUND: The pathophysiology of levodopa-induced dyskinesia (LID) in Parkinson’s disease (PD) is not well understood. Experimental data from numerous investigations support the idea that aberrant activity of D(1) dopamine receptor-positive medium spiny neurons in the striatal direct pathway is as...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gao, Shasha, Gao, Rui, Yao, Lu, Feng, Jie, Liu, Wanyuan, Zhou, Yingqiong, Zhang, Qiongchi, Wang, Yong, Liu, Jian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Aging Neuroscience
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8850470/ https://www.ncbi.nlm.nih.gov/pubmed/35185524 http://dx.doi.org/10.3389/fnagi.2022.783893

Ejemplares similares

Axon terminal hypertrophy of striatal projection neurons with levodopa-induced dyskinesia priming
por: Nakamura, Takashi, et al.
Publicado: (2023)

Pallidal Structural Changes Related to Levodopa-induced Dyskinesia in Parkinson's Disease
por: Youn, Jinyoung, et al.
Publicado: (2022)

Histological Correlates of Neuroanatomical Changes in a Rat Model of Levodopa-Induced Dyskinesia Based on Voxel-Based Morphometry
por: Zhang, Xiaoqian, et al.
Publicado: (2021)

Serum zinc deficiency is a potential risk factor for the occurrence of levodopa-induced dyskinesia in drug-naïve Parkinson’s disease
por: Kim, Joung Eun, et al.
Publicado: (2023)

Maladaptive Plasticity in Levodopa-Induced Dyskinesias and Tardive Dyskinesias: Old and New Insights on the Effects of Dopamine Receptor Pharmacology
por: Cerasa, Antonio, et al.
Publicado: (2014)

Effects of levodopa on gut bacterial antibiotic resistance in Parkinson’s disease rat
por: Sheng, Shuo, et al.
Publicado: (2023)

Morphologic brain network predicts levodopa responsiveness in Parkinson disease
por: Xie, Yongsheng, et al.
Publicado: (2023)

Striatal Gα(olf)/cAMP Signal-Dependent Mechanism to Generate Levodopa-Induced Dyskinesia in Parkinson’s Disease
por: Goto, Satoshi
Publicado: (2017)

“Cueing” for Levodopa-Induced Dyskinesias in Parkinson’s Disease
por: Schaeffer, Eva, et al.
Publicado: (2016)

Spine Enlargement of Pyramidal Tract-Type Neurons in the Motor Cortex of a Rat Model of Levodopa-Induced Dyskinesia
por: Ueno, Tatsuya, et al.
Publicado: (2017)

Pitx3 deficiency promotes age-dependent alterations in striatal medium spiny neurons
por: Chen, Xi, et al.
Publicado: (2022)

Opioidergic Modulation of Striatal Circuits, Implications in Parkinson's Disease and Levodopa Induced Dyskinesia
por: Sgroi, Stefania, et al.
Publicado: (2018)

Future Scenarios for Levodopa-Induced Dyskinesias in Parkinson’s Disease
por: Cerasa, Antonio, et al.
Publicado: (2015)

L-DOPA-Induced Dyskinesia and Abnormal Signaling in Striatal Medium Spiny Neurons: Focus on Dopamine D1 Receptor-Mediated Transmission
por: Feyder, Michael, et al.
Publicado: (2011)

Effect of Zishenpingchan Granule on Neurobehavioral Manifestations and the Activity and Gene Expression of Striatal Dopamine D1 and D2 Receptors of Rats with Levodopa-Induced Dyskinesias
por: Ye, Qing, et al.
Publicado: (2014)

Brain-Region Specific Metabolic Abnormalities in Parkinson’s Disease and Levodopa-Induced Dyskinesia
por: Yang, Changwei, et al.
Publicado: (2020)

Levodopa Reverses Cytokine-Induced Reductions in Striatal Dopamine Release
por: Felger, Jennifer C., et al.
Publicado: (2015)

Basal Ganglia Circuits Underlying the Pathophysiology of Levodopa-Induced Dyskinesia
por: Barroso-Chinea, Pedro, et al.
Publicado: (2010)

Cerebellum in Levodopa-Induced Dyskinesias: The Unusual Suspect in the Motor Network
por: Kishore, Asha, et al.
Publicado: (2014)

Dopamine pathway and Parkinson's risk variants are associated with levodopa-induced dyskinesia
por: Sosero, Yuri L., et al.
Publicado: (2023)

Genetic silencing of striatal CaV1.3 prevents and ameliorates levodopa dyskinesia
por: Steece‐Collier, Kathy, et al.
Publicado: (2019)

Evolution characteristics of dynamic balance disorder over the course of PD and relationship with dopamine depletion
por: Gan, Jing, et al.
Publicado: (2023)

Regulation of dopamine neurotransmission from serotonergic neurons by ectopic expression of the dopamine D2 autoreceptor blocks levodopa-induced dyskinesia
por: Sellnow, Rhyomi C., et al.
Publicado: (2019)

Resveratrol Alleviates Levodopa-Induced Dyskinesia in Rats
por: Zheng, Chang-Qing, et al.
Publicado: (2021)

Nigral Iron Deposition Is Associated With Levodopa-Induced Dyskinesia in Parkinson’s Disease
por: Song, Tianbin, et al.
Publicado: (2021)

Corrigendum: Diagnostic value of striatal (18)F-FP-DTBZ PET in Parkinson's disease
por: Liu, Xiu-Lin, et al.
Publicado: (2022)

Behavioral effects of zonisamide on L-DOPA-induced dyskinesia in Parkinson's disease model mice
por: Sano, Hiromi, et al.
Publicado: (2023)

Mechanisms for the Modulation of Dopamine D(1) Receptor Signaling in Striatal Neurons
por: Nishi, Akinori, et al.
Publicado: (2011)

Controlled-release levodopa methyl ester/benserazide-loaded nanoparticles ameliorate levodopa-induced dyskinesia in rats
por: Yang, Xinxin, et al.
Publicado: (2012)

Altered Neuronal Firing Pattern of the Basal Ganglia Nucleus Plays a Role in Levodopa-Induced Dyskinesia in Patients with Parkinson’s Disease
por: Li, Xiaoyu, et al.
Publicado: (2015)

Senescence in Primary Rat Astrocytes Induces Loss of the Mitochondrial Membrane Potential and Alters Mitochondrial Dynamics in Cortical Neurons
por: Morales-Rosales, Sandra Lizbeth, et al.
Publicado: (2021)

A Meta-Analysis of Adenosine A2A Receptor Antagonists on Levodopa-Induced Dyskinesia In Vivo
por: Wang, Wen-Wen, et al.
Publicado: (2017)

Evidence for Dopamine Abnormalities Following Acute Methamphetamine Exposure Assessed by Neuromelanin-Sensitive Magnetic Resonance Imaging
por: Tang, Fei, et al.
Publicado: (2022)

Interactions of CaMKII with dopamine D2 receptors: roles in levodopa-induced dyskinesia in 6-hydroxydopamine lesioned Parkinson's rats
por: Zhang, SuFang, et al.
Publicado: (2014)

Downregulation of striatal Ca(V)1.3 inhibits the escalation of levodopa-induced dyskinesia in male and female parkinsonian rats of advanced age
por: Caulfield, Margaret E., et al.
Publicado: (2023)

Striatal Plasticity in L-DOPA- and Graft-Induced Dyskinesia; The Common Link?
por: Rylander Ottosson, Daniella, et al.
Publicado: (2016)

Riluzole Administration to Rats with Levodopa-Induced Dyskinesia Leads to Loss of DNA Methylation in Neuronal Genes
por: Pagliaroli, Luca, et al.
Publicado: (2021)

Local control of striatal dopamine release
por: Cachope, Roger, et al.
Publicado: (2014)

LOW DOSE LEVODOPA IN TARDIVE DYSKINESIA
por: Sethi, Sujata, et al.
Publicado: (1990)

Involvement of Autophagy in Levodopa‐Induced Dyskinesia
por: Feyder, Michael, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_96efg31km8u3tpvmoielcu151n